Renaissance Group LLC Dr Reddys Laboratories LTD Transaction History

Renaissance Group LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$48.27 - $65.25 $6.11 Million - $8.25 Million	-126,492 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$59.5 - $67.25 $909,100 - $1.03 Million	-15,279 Reduced 10.78%	126,492 $8.27 Million
Q3 2021 Nov 12, 2021	SELL	$60.19 - $75.29 $657,936 - $822,994	-10,931 Reduced 7.16%	141,771 $9.24 Million
Q2 2021 Aug 13, 2021	SELL	$62.12 - $74.2 $657,167 - $784,961	-10,579 Reduced 6.48%	152,702 $11.2 Million
Q1 2021 May 13, 2021	SELL	$57.98 - $73.08 $363,766 - $458,503	-6,274 Reduced 3.7%	163,281 $10 Million

Q4 2020 Feb 12, 2021	SELL	$62.61 - $71.29 $580,332 - $660,787	-9,269 Reduced 5.18%	169,555 $12.1 Million
Q3 2020 Nov 12, 2020	SELL	$51.39 - $72.41 $1.36 Million - $1.92 Million	-26,449 Reduced 12.88%	178,824 $12.4 Million
Q2 2020 Aug 12, 2020	SELL	$39.55 - $54.65 $930,097 - $1.29 Million	-23,517 Reduced 10.28%	205,273 $10.9 Million
Q1 2020 May 06, 2020	BUY	$34.75 - $45.85 $7.95 Million - $10.5 Million	228,790 New	228,790 $9.23 Million

242

23.6M

25.2K

8.5K

Ticker RDY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 166,028,992
Market Cap $12.6B
Description
Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...

Get notified when there are updates to the investment portfolio of Renaissance Group LLC, based on Form 13F filings with the SEC.

Stay updated on Renaissance Group LLC with notifications on news.